Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

One-stage laparoendoscopic approach for gallbladder and common bile duct stones

Official title: Laparoendoscopic Rendezvous for Difficult Cholecystocholedocholithiasis.

Run by Minia University · NCT07008170 · Data updated 2026-11-12

This trial tests whether a single-operation laparoendoscopic 'rendezvous' approach—combining laparoscopic gallbladder removal with endoscopic bile duct clearance—works safely and effectively for patients with both gallbladder and common bile duct stones.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorMinia University
Academic / other
Locations1 site (Minya)
StatusRecruiting
StartedJune 15, 2025
Main results expectedJune 15, 2026
Study endsJuly 15, 2026
Registry record updatedJune 19, 2025
Trial IDNCT07008170 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with confirmed or highly suspected concomitant gallbladder and common bile duct stones who are fit for general anesthesia and endoscopic procedures and have not had complex prior hepatobiliary surgery.

Probably not a fit

Patients with prior major hepatobiliary or upper abdominal resections, morbid obesity, uncorrectable coagulopathy, pregnancy, or who decline consent are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective interventional study compares a one-stage laparoendoscopic rendezvous technique (intraoperative endoscopic sphincterotomy with laparoscopic cholecystectomy) against the conventional two-stage approach (preoperative ERCP followed by laparoscopic cholecystectomy) for cholecystocholedocholithiasis. Patients are enrolled based on imaging or laboratory evidence of concurrent or highly suspected common bile duct stones and must be fit for general anesthesia and endoscopic procedures. The main outcomes are stone clearance, technical success including difficult cannulation rates, procedure-related complications, and postoperative recovery. Procedures and follow-up are conducted at a single center to document efficacy and safety.

Why it matters

Potential benefit: If successful, the one-stage approach could clear both gallbladder and bile duct stones in a single operation, reducing total procedures, hospital time, and anesthesia exposure.

How similar studies have gone: Laparoendoscopic rendezvous has been reported in adult case series to improve cannulation success and reduce the need for two separate procedures, though randomized and pediatric data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients having stone(s) in the gallbladder and concurrent common bile duct , as determined by MRCP(magnetic resonance cholangiopancreatography) or US.
* Patients with acute cholecystitis, acute cholangitis, obstructive jaundice, and those with highly suspicious criteria for common bile duct stones, such as dilated CBD( common bile duct ) on US examination \> 7 mm in diameter without obvious common bile duct stones, high serum bilirubin level, and/or high serum alkaline phosphatase level, were also included in this study. (high risk for cholecystocholedocholithiasis)
* Previous failed ERCP attempt
* Patients fit for general anesthesia and tolerant of pneumoperitoneum and endoscopic procedures.

Exclusion Criteria:

* History of hepatobiliary surgery as choledochoduodenal anastomosis
* A Previous upper abdominal surgery as total or partial gastric resection.
* Morbid obesity.
* Uncorrectable coagulopathy.
* Patients who refused to give consent.
* Pregnancy.
* Suspected malignant biliary stricture or cholangiocarcinoma
* Severe acute cholangitis with hemodynamic instability or septic shock requiring immediate biliary drainage (may necessitate emergent ERCP or percutaneous drainage first)
* Impacted CBD stones or stones deemed too large for endoscopic extraction (e.g., \> 1.5 cm)
* Severe cardiopulmonary disease significantly increasing operative risk.
* Intrahepatic bile duct stones with indications for surgery.
* Patients with choledocholithiasis \>2 cm or a large number of stones were difficult to remove.

Where it's running

  • Liver and GIT hospital , Minia University
    Minya, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.